Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
*Includes escrow
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
Presentations & Interviews
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Corporate Governance
Media
Financial Reports
Annual Reports
Half Yearly Reports
Newsletters
Analyst Reports
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
Presentations & Interviews
>
Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021
Investor Welcome
ASX Announcements
Presentations & Interviews
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Corporate Governance
Media
Financial Reports
Annual Reports
Half Yearly Reports
Newsletters
Analyst Reports
Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021
